[{"notes_id":"1_1134","category":"3","subcategory":"1","title":"Diabetic ketoacidosis","body":"Diabetic ketoacidosis (DKA) may be a complication of existing type 1 diabetes mellitus or be the first presentation, accounting for around 6% of cases.  Rarely, under conditions of extreme stress, patients with <span class=\"concept\" data-cid=\"5494\">type 2 diabetes mellitus<\/span> may also develop DKA.<br \/><br \/>Whilst DKA remains a serious condition, mortality rates have decreased from 8% to under 1% in the past 20 years.<br \/><br \/>Pathophysiology<br \/><ul><li><span class=\"concept\" data-cid=\"7735\">DKA is caused by uncontrolled lipolysis (not proteolysis) which results in an excess of free fatty acids that are ultimately converted to ketone bodies<\/span><\/li><\/ul><br \/>The most common precipitating factors of DKA are infection, missed insulin doses and <span class=\"concept\" data-cid=\"3699\">myocardial infarction<\/span>.<br \/><br \/>Features<br \/><ul><li><span class=\"concept\" data-cid=\"5413\">abdominal pain<\/span><\/li><li>polyuria, polydipsia, dehydration<\/li><li>Kussmaul respiration (deep hyperventilation)<\/li><li>Acetone-smelling breath ('pear drops' smell)<\/li><\/ul><br \/><h5 class='notes-heading'>Diagnostic criteria<\/h5><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>American Diabetes Association (2009)<\/th><th>Joint British Diabetes Societies (2013)<\/th><\/tr><\/thead><tbody><tr><td>Key points<br \/><ul><li>glucose > 13.8 mmol\/l<\/li><li>pH < 7.30<\/li><li>serum bicarbonate <18 mmol\/l<\/li><li>anion gap > 10<\/li><li>ketonaemia<\/td><td><\/li><\/ul>Key points<br \/><ul><li>glucose > 11 mmol\/l or known diabetes mellitus<\/li><li>pH < 7.3<\/li><li>bicarbonate < 15 mmol\/l<\/li><li><span class=\"concept\" data-cid=\"5493\">ketones > 3 mmol\/l<\/span> or urine ketones ++ on dipstick<\/td><\/tr><\/tbody><\/table><\/div><\/li><\/ul><br \/><h5 class='notes-heading'>Management<\/h5><br \/>Main principles of management<br \/><ul><li>fluid replacement<ul><li>most patients with DKA are deplete around 5-8 litres<\/li><li><span class=\"concept\" data-cid=\"11273\">isotonic saline<\/span> is used initially, even if the patient is severely acidotic<\/li><li>please see an example fluid regime below.<\/li><\/ul><\/li><li>insulin<ul><li>an intravenous infusion should be started at <span class=\"concept\" data-cid=\"11414\">0.1 unit\/kg\/hour<\/span><\/li><li>once blood glucose <span class=\"concept\" data-cid=\"11983\">is < 14 mmol\/l an infusion of 10% dextrose should be started at 125 mls\/hr <i>in addition<\/i> to the 0.9% sodium chloride regime<\/span><\/li><\/ul><\/li><li>correction of electrolyte disturbance<ul><li>serum potassium is often high on admission despite total body potassium being low<\/li><li>this often falls quickly following treatment with insulin resulting in hypokalaemia<\/li><li>potassium may therefore need to be added to the replacement fluids<\/li><li>if the rate of potassium infusion is greater than 20 mmol\/hour then cardiac monitoring may be required<\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"1234\">long-acting insulin should be continued, short-acting insulin should be stopped<\/span><\/li><\/ul><br \/><h6 class='notes-subheading'>JBDS example of fluid replacement regime for patient with a systolic BP on admission 90mmHg and over<\/h6><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th>Fluid<\/th><th>Volume<\/th><\/tr><\/thead><tbody><tr><td>0.9% sodium chloride 1L<\/td><td>1000ml over 1st hour<\/td><\/tr><tr><td>0.9% sodium chloride 1L with potassium chloride<\/td><td>1000ml over next 2 hours<\/td><\/tr><tr><td>0.9% sodium chloride 1L with potassium chloride<\/td><td>1000ml over next 2 hours<\/td><\/tr><tr><td>0.9% sodium chloride 1L with potassium chloride<\/td><td>1000ml over next 4 hours<\/td><\/tr><tr><td>0.9% sodium chloride 1L with potassium chloride<\/td><td>1000ml over next 4 hours<\/td><\/tr><tr><td>0.9% sodium chloride 1L with potassium chloride<\/td><td>1000ml over next 6 hours<\/td><\/tr><\/tbody><\/table><\/div><br \/>Please note that slower infusion may be indicated in young adults (aged 18-25 years) as they are at greater risk of cerebral oedema.<br \/><br \/><h6 class='notes-subheading'>JBDS potassium guidelines<\/h6><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid3\" ><thead><tr><th>Potassium level in first 24 hours (mmol\/L)<\/th><th>Potassium replacement in mmol\/L of infusion solution<\/th><\/tr><\/thead><tbody><tr><td>Over 5.5<\/td><td>Nil<\/td><\/tr><tr><td>3.5-5.5<\/td><td><span class=\"concept\" data-cid=\"11276\">40<\/span><\/td><\/tr><tr><td>Below 3.5<\/td><td>Senior review as additional potassium needs to be given<\/td><\/tr><\/tbody><\/table><\/div><br \/><h5 class='notes-heading'>Resolution<\/h5><br \/><span class=\"concept\" data-cid=\"2649\">DKA resolution is defined<\/span> as:<br \/><ul><li>pH >7.3 and <\/li><li>blood ketones < 0.6 mmol\/L and<\/li><li>bicarbonate > 15.0mmol\/L<\/li><\/ul> <br \/>Further points<br \/><ul><li>both the <span class=\"concept\" data-cid=\"11277\">ketonaemia and acidosis should have been resolved within 24 hours<\/span>. If this hasn't happened the patient requires senior review from an endocrinologist<\/li><li>if the above criteria are met and the patient is eating and drinking switch to subcutaneous insulin<\/li><li>the patient should be reviewed by the diabetes specialist nurse prior to discharge<\/li><\/ul><br \/><h5 class='notes-heading'>Complications<\/h5><br \/>Complications may occur from DKA itself or the treatment:<br \/><ul><li>gastric stasis<\/li><li>thromboembolism<\/li><li>arrhythmias secondary to hyperkalaemia\/iatrogenic hypokalaemia<\/li><li>iatrogenic due to incorrect fluid therapy: <span class=\"concept\" data-cid=\"1290\">cerebral oedema<\/span>*, hypokalaemia, hypoglycaemia<\/li><li>acute respiratory distress syndrome<\/li><li>acute kidney injury<\/li><\/ul><br \/>* <span class=\"concept\" data-cid=\"1290\">children\/young adults are particularly vulnerable to cerebral oedema<\/span> following fluid resuscitation in DKA and often need 1:1 nursing to monitor neuro-observations, headache, irritability, visual disturbance, focal neurology etc. It usually occurs 4-12 hours following commencement of treatment but can present at any time. If there is any suspicion a CT head and senior review should be sought","notes_hash":"22116a034fe21294322cc27e68874af2","knowledge_graph_node_id_link":1066,"links":"<table style='width:100%'><tr><td>Joint British Inpatient Diabetes Societies Inpatient Care Group<\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1025\" data-linkid=\"1025\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"link_good_count_1025\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">32<\/span><button type=\"button\" style=\"\" id=\"link_dislike_1025\" data-linkid=\"1025\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"link_bad_count_1025\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">24<\/span><\/td><\/tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https:\/\/abcd.care\/sites\/abcd.care\/files\/site_uploads\/JBDS_Guidelines_Current\/JBDS_02_DKA_Guideline_with_QR_code_March_2023.pdf\">The Management of Diabetic ketoacidosis in adults<\/a><\/td><\/tr><\/table>","media":"<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/-B-RVybvffU\" data-description=\"Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"14\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/-B-RVybvffU\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/-B-RVybvffU\" data-description=\"Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"14\">Diabetes mellitus (type 1, type 2) &amp; diabetic ketoacidosis (DKA) - causes &amp; symptoms<\/a><\/td><\/tr><tr><td><span ><small>Osmosis - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1783\" data-mediaid=\"1783\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_1783\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2<\/span><button type=\"button\" style=\"\" id=\"media_dislike_1783\" data-mediaid=\"1783\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_1783\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1<\/span><\/td><\/tr><tr><td>&nbsp;<\/td><\/tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/FxOXPVW4ZCc\" data-description=\"Diabetic Ketoacidosis (Diabetes Type I) Management Summary\" data-upvotes=\"5\" data-downvotes=\"3\" data-media=\"399\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https:\/\/i1.ytimg.com\/vi\/FxOXPVW4ZCc\/mqdefault.jpg\" style=\"max-width:150px;\"><\/a><\/td><\/tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https:\/\/www.youtube.com\/embed\/FxOXPVW4ZCc\" data-description=\"Diabetic Ketoacidosis (Diabetes Type I) Management Summary\" data-upvotes=\"5\" data-downvotes=\"3\" data-media=\"399\">Diabetic Ketoacidosis (Diabetes Type I) Management Summary<\/a><\/td><\/tr><tr><td><span ><small>Armando Hasudungan - YouTube<\/small><\/span><\/td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_683\" data-mediaid=\"683\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"\/><\/svg><\/button><span id=\"media_good_count_683\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5<\/span><button type=\"button\" style=\"\" id=\"media_dislike_683\" data-mediaid=\"683\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"\/><\/svg><\/button><span id=\"media_bad_count_683\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">3<\/span><\/td><\/tr><\/table>","concepts_for_notes":{"1234":{"concept_text":"In the acute management of DKA, insulin should be fixed rate whilst continuing regular injected long-acting insulin but stopping short actin injected insulin","concept_percentile":"57"},"5413":{"concept_text":"Abdominal pain may be the presenting symptom in DKA\r\n","concept_percentile":"64"}},"category_name":"Endocrinology \/ Metabolic","subcategory_name":"Endocrinology","comment_count":13},"",[]]